New York State Common Retirement Fund Has $19.03 Million Stock Holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

New York State Common Retirement Fund trimmed its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 3.4% during the fourth quarter, HoldingsChannel.com reports. The fund owned 243,450 shares of the company’s stock after selling 8,500 shares during the period. New York State Common Retirement Fund’s holdings in GE HealthCare Technologies were worth $19,033,000 at the end of the most recent quarter.

A number of other hedge funds have also modified their holdings of the company. Braun Stacey Associates Inc. raised its holdings in GE HealthCare Technologies by 0.4% in the fourth quarter. Braun Stacey Associates Inc. now owns 221,509 shares of the company’s stock worth $17,318,000 after purchasing an additional 900 shares during the period. Atria Wealth Solutions Inc. raised its stake in GE HealthCare Technologies by 40.8% during the 4th quarter. Atria Wealth Solutions Inc. now owns 32,583 shares of the company’s stock worth $2,547,000 after buying an additional 9,444 shares during the period. D.A. Davidson & CO. raised its stake in GE HealthCare Technologies by 89.7% during the 4th quarter. D.A. Davidson & CO. now owns 8,959 shares of the company’s stock worth $700,000 after buying an additional 4,237 shares during the period. Truist Financial Corp raised its position in shares of GE HealthCare Technologies by 1.9% during the fourth quarter. Truist Financial Corp now owns 82,770 shares of the company’s stock worth $6,471,000 after purchasing an additional 1,528 shares during the period. Finally, CIBC Asset Management Inc raised its position in shares of GE HealthCare Technologies by 3.5% during the fourth quarter. CIBC Asset Management Inc now owns 146,218 shares of the company’s stock worth $11,431,000 after purchasing an additional 5,009 shares during the period. 82.06% of the stock is currently owned by institutional investors and hedge funds.

GE HealthCare Technologies Stock Down 1.1 %

Shares of GEHC stock opened at $91.09 on Friday. The company has a current ratio of 1.04, a quick ratio of 0.83 and a debt-to-equity ratio of 0.88. The firm’s fifty day moving average price is $85.05 and its two-hundred day moving average price is $85.86. The firm has a market capitalization of $41.66 billion, a P/E ratio of 21.04, a PEG ratio of 3.19 and a beta of 1.15. GE HealthCare Technologies Inc. has a 1 year low of $74.51 and a 1 year high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings results on Thursday, February 13th. The company reported $1.45 EPS for the quarter, beating the consensus estimate of $1.26 by $0.19. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. The firm had revenue of $5.32 billion during the quarter, compared to analysts’ expectations of $5.33 billion. On average, equities analysts predict that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities research analysts have recently commented on GEHC shares. Wells Fargo & Company raised their price target on GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an “overweight” rating in a research report on Friday, February 14th. Jefferies Financial Group upgraded shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and raised their price objective for the stock from $95.00 to $103.00 in a report on Wednesday, January 8th. Finally, Citigroup raised their price objective on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a “buy” rating in a report on Thursday, February 13th. One analyst has rated the stock with a sell rating, three have given a hold rating, eight have issued a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, GE HealthCare Technologies has a consensus rating of “Moderate Buy” and a consensus price target of $97.67.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.